SYDNEY, June 9, 2026, 06:04 (AEST)
Pro Medicus is coming off a 25.2% gain for the week, but now faces a new headwind when the ASX opens Tuesday. S&P Dow Jones Indices said it will kick the medical-imaging software group out of the S&P/ASX 50 after June 22. ALS will move into the index.
Index changes can hit hard when markets are shut. With the Australian cash market closed Monday for the King’s Birthday, Friday’s close is still the last price until trading is back on. A rebalance just means an index provider switches up which stocks are in the benchmark.
Pro Medicus closed Friday at A$165.64, up A$6.41, or 4.03%, while the ASX 200 dropped 0.7% to 8,625.10. The stock is up 24.74% in the past four weeks, but remains off about 40% for the past year. Last week’s jump followed a steep selloff.
The stock jump came after new contract news. Pro Medicus told the market on June 4 its U.S. arm, Visage Imaging, locked in a five-year, A$16 million extension with The Ohio State University Wexner Medical Center. The deal brings Visage 7 Workflow and Visage 7 Cardiology Imaging into the mix. Pro Medicus said this is a transaction-based contract, so revenue will depend on usage as well as minimum volumes.
Ohio State’s renewal pushed Pro Medicus’ renewals this financial year to A$141 million, Chief Executive Dr Sam Hupert said. “This contract brings our total renewals for the financial year to A$141M,” Hupert said. He said the deal backed the company’s retention outlook.
A few days earlier, Pro Medicus signed a five-year renewal with Allegheny Health Network worth A$28 million. The company said the deal adds Visage 7 Workflow and comes with higher minimums and higher per-transaction fees. CEO Sam Hupert said this is Allegheny’s third contract term with Pro Medicus, saying it “reflect[s] the strength” of the ongoing partnership. ASX Announcements
AI worries also linger over the stock. In a June 1 interview via ASX, Hupert said concerns that AI could damage software subscription firms have pressured Pro Medicus shares. He called the drop a “knee-jerk reaction”. He also said AI is “a big opportunity” for the company. ASX Announcements
Hupert also responded to worries about big system deployment revenue falling short. “The Trinity rollout is 100% on schedule,” he said. He added that most of the revenue from recent go-lives will come in fiscal 2027, with little hitting this half. ASX Announcements
Competition is active in picture archiving and communication systems, or PACS. KLAS Research said Sectra got the most consideration and selections in the past two years. Pro Medicus’ Visage Imaging had the second-highest number of new selections, according to KLAS. KLAS also said Philips and GE HealthCare customers were among those most frequently weighing alternatives.
The risk from dropping out of the index is different. The S&P/ASX 50 tracks 50 of the biggest and most traded names on the ASX, and there are products tied to it. Pro Medicus leaving the index could spur some forced selling or at least cut demand from investors who follow the benchmark, even if hospital demand for its software stays steady.
The downside looks straightforward. Shares have jumped 25% in a short time, so they could slip if index funds start selling in thin, holiday-shortened trading. Some investors might also get impatient with fiscal 2027’s revenue ramp being so far off, or worry about a stronger Australian dollar cutting into U.S. revenue. Hupert said roughly 90% of revenue now comes from the U.S. and is billed in U.S. dollars.
S&P/ASX 50 pricing comes back into focus this week as traders return after the holiday and look at new contract wins. The next set marker is June 12, when S&P Dow Jones Indices plans to release updated data for capped and equal-weighted indices ahead of the June 22 effective date.
